Case File №
#VI-2026-0130
UWA Elite Peptides
Request Full Data Access to the VendorInvestigate database of peptide tests.
Exhibit I
Compounds on File
41 LINE ITEMS| Compound | Grade | Samples | Mean | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Retatrutide | E Bad | 11 | 6.3 | 2.7 | 8.8 | 16 Jul 2025 |
| Tirzepatide | E Bad | 5 | 5.3 | 2.2 | 8.3 | 5 Aug 2025 |
| 1-Boc-4-(4-fluorophenylamino)piperidine CAS 288573-56-8 | X N/A | 1 | 6.0 | 6.0 | 6.0 | 14 Jan 2025 |
| 17a-Methyl-1-Testosterone | X N/A | 1 | 5.7 | 5.7 | 5.7 | 3 Jul 2025 |
| 5-amino-1MQ | X N/A | 1 | 4.6 | 4.6 | 4.6 | 3 Jul 2025 |
| ACE-031 | X N/A | 1 | 4.3 | 4.3 | 4.3 | 3 Jul 2025 |
| AHK-CU | X N/A | 1 | 4.7 | 4.7 | 4.7 | 20 Jun 2025 |
| Alprostadil | X N/A | 1 | 5.3 | 5.3 | 5.3 | 7 May 2025 |
| Arimidex (Anastrozole) | X N/A | 1 | 7.0 | 7.0 | 7.0 | 14 Jan 2025 |
| BMK glycidic acid (P-2-P methyl glycidic acid / sodium salt) CAS 5449-12-7 | X N/A | 1 | 4.8 | 4.8 | 4.8 | 14 Jan 2025 |
| Cardiogen | X N/A | 1 | 4.9 | 4.9 | 4.9 | 8 Jul 2025 |
| Cerebrolysin | X N/A | 1 | 6.6 | 6.6 | 6.6 | 2 Apr 2025 |
| Chonluten | X N/A | 1 | 6.9 | 6.9 | 6.9 | 24 Apr 2025 |
| Clenbuterol | X N/A | 1 | 4.4 | 4.4 | 4.4 | 6 May 2025 |
| DSIP | X N/A | 1 | 5.2 | 5.2 | 5.2 | 2 Apr 2025 |
| Flibanserin | X N/A | 1 | 6.7 | 6.7 | 6.7 | 28 Mar 2025 |
| GHRP-2 Acetate | X N/A | 1 | 6.5 | 6.5 | 6.5 | 11 Jun 2025 |
| GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | X N/A | 1 | 5.7 | 5.7 | 5.7 | 25 Apr 2025 |
| HGH 191AA (Somatropin) | X N/A | 1 | 6.9 | 6.9 | 6.9 | 8 Jul 2025 |
| Hyaluronic acid | X N/A | 1 | 8.1 | 8.1 | 8.1 | 14 Jan 2025 |
| IGF-1 LR3 | X N/A | 1 | 7.3 | 7.3 | 7.3 | 16 Mar 2025 |
| L-Carnitine 500mg | X N/A | 1 | 8.1 | 8.1 | 8.1 | 3 Jul 2025 |
| Livagen | X N/A | 1 | 4.5 | 4.5 | 4.5 | 13 Jun 2025 |
| Masteron P (Drostanolone P) | X N/A | 1 | 5.4 | 5.4 | 5.4 | 17 Dec 2024 |
| MT-1 | X N/A | 1 | 6.4 | 6.4 | 6.4 | 28 Mar 2025 |
| NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | X N/A | 1 | 6.6 | 6.6 | 6.6 | 28 Mar 2025 |
| NAD+ | X N/A | 1 | 5.7 | 5.7 | 5.7 | 13 Jun 2025 |
| PE 22-28 | X N/A | 1 | 6.8 | 6.8 | 6.8 | 20 Jun 2025 |
| PEG MGF | X N/A | 1 | 6.1 | 6.1 | 6.1 | 16 Mar 2025 |
| Retatrutide 5mg + Cagrilintide 5mg Blend | X N/A | 1 | 6.1 | 6.1 | 6.1 | 13 Feb 2025 |
| RIPEX 225 (TRA/Mast P/Test P) | X N/A | 1 | 4.0 | 2.0 | 2.0 | 6 May 2025 |
| Selank | X N/A | 1 | 6.4 | 6.4 | 6.4 | 14 Jan 2025 |
| Sleep Blend (GABA 100mg+Histidine 100mg+L-Theanine 50mg+Taurine 100mg+Melatonin 2mg) | X N/A | 1 | 5.9 | 5.9 | 5.9 | 13 Feb 2025 |
| Super Shred | X N/A | 1 | 4.1 | 4.1 | 4.1 | 25 Apr 2025 |
| T3 (Liothyronine) | X N/A | 1 | 8.2 | 8.2 | 8.2 | 13 Feb 2025 |
| Test Suspension | X N/A | 1 | 6.3 | 6.3 | 6.3 | 8 Jul 2025 |
| Testosterone Decanoate Raw | X N/A | 1 | 4.3 | 4.3 | 4.3 | 14 Jan 2025 |
| Thymalin | X N/A | 1 | 6.8 | 6.8 | 6.8 | 3 Jul 2025 |
| Trenbolone Acetate | X N/A | 1 | 7.2 | 7.2 | 7.2 | 14 Jan 2025 |
| Trestolone Enanthate Raw | X N/A | 1 | 4.8 | 4.8 | 4.8 | 3 Jun 2025 |
| Vitamin B12 1mg/ml | X N/A | 1 | 7.5 | 7.5 | 7.5 | 13 Jun 2025 |
Exhibit II
Evidence Log
46 LABORATORY RETURNS| Filed | Compound | Score | Claimed | Found | Δ Qty | Purity | Batch № | Lab | Source |
|---|---|---|---|---|---|---|---|---|---|
| 25 May 2026 | Arimidex (Anastrozole) | 8.8 A | 25mg | 30.9mg | +23.5% | 95.11% | 1qzuer | Lab B | Community |
| 25 May 2026 | Masteron P (Drostanolone P) | 5.7 B | 300mg/ml | 312.1mg/ml | +4.0% | 96.78% | z502e4 | Lab G | Community |
| 24 May 2026 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 9.6 A | 2mg | 1.8mg | -11.6% | 99.93% | mjyvjm | Lab G | Community |
| 24 May 2026 | IGF-1 LR3 | 9.9 A | 10mg | 9.3mg | -6.8% | 97.15% | 0zwlp9 | Lab E | Public |
| 24 May 2026 | Hyaluronic acid | 8.0 A | 50mg | 58.9mg | +17.8% | 98.81% | iubrii | Lab E | Public |
| 24 May 2026 | MT-1 | 6.8 A | 30mg | 35.9mg | +19.6% | 98.60% | auoimx | Lab F | Public |
| 24 May 2026 | Trenbolone Acetate | 7.9 A | 250mg/ml | 286.1mg/ml | +14.4% | 95.25% | l7rbku | Lab G | Public |
| 24 May 2026 | 17a-Methyl-1-Testosterone | 4.6 C | 25mg | 25.2mg | +0.7% | 96.09% | pwqlkg | Lab E | Public |
| 24 May 2026 | 5-amino-1MQ | 4.0 C | 2mg | 2.5mg | +24.6% | 98.38% | iiz59v | Lab F | Public |
| 24 May 2026 | L-Carnitine 500mg | 9.1 A | 300mg/ml | 370.6mg/ml | +23.5% | 96.32% | 6czp65 | Lab F | Community |
| 24 May 2026 | Sleep Blend (GABA 100mg+Histidine 100mg+L-Theanine 50mg+Taurine 100mg+Melatonin 2mg) | 8.0 A | 250mg/ml | 237.9mg/ml | -4.8% | 98.10% | qqwerm | Lab A | Community |
| 24 May 2026 | GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | 6.4 A | 20mg | 23.0mg | +14.8% | 96.28% | e8ip2e | Lab A | Public |
| 24 May 2026 | HGH 191AA (Somatropin) | 4.2 C | 50mg | 55.2mg | +10.4% | 97.81% | nlhelf | Lab C | Public |
| 24 May 2026 | NAD+ | 5.8 B | 15mg | 15.2mg | +1.0% | 95.91% | rjct1p | Lab A | Public |
| 24 May 2026 | Selank | 5.6 B | 15mg | 17.7mg | +18.1% | 96.96% | b6ucjs | Lab E | Community |
| 23 May 2026 | Tirzepatide | 8.3 A | 30mg | 29.9mg | -0.3% | 99.17% | 59208 | Lab E | Public |
| 23 May 2026 | BMK glycidic acid (P-2-P methyl glycidic acid / sodium salt) CAS 5449-12-7 | 4.0 C | 100g | 116.6g | +16.6% | 99.21% | c36n6s | Lab F | Community |
| 23 May 2026 | T3 (Liothyronine) | 8.4 A | 10mg | 11.8mg | +17.7% | 98.77% | j0zluo | Lab F | Community |
| 23 May 2026 | Thymalin | 4.2 C | 50mg | 43.9mg | -12.1% | 95.94% | xfop8x | Lab F | Public |
| 23 May 2026 | Clenbuterol | 6.6 A | 10mg | 11.0mg | +9.6% | 97.52% | hnijub | Lab B | Community |
| 21 May 2026 | Retatrutide | 8.8 A | 10mg | 9.12mg | -8.8% | 99.90% | 94813 | Lab E | Public |
| 21 May 2026 | Cardiogen | 4.0 C | 2mg | 2.2mg | +9.8% | 99.65% | otqr4d | Lab D | Public |
| 19 May 2026 | Flibanserin | 6.9 A | 50mg | 44.1mg | -11.9% | 95.66% | 09dmq0 | Lab E | Community |
| 29 Jan 2026 | Retatrutide | 8.0 A | 10mg | 10.7mg | +7.0% | 99.33% | 12022025 | Lab E | Public |
| 29 Jan 2026 | Retatrutide | 7.0 A | 20mg | 20.5mg | +2.5% | 97.50% | 12022025 | Lab E | Public |
| 29 Jan 2026 | GHRP-2 Acetate | 5.3 B | 10mg | 10.2mg | +2.2% | 95.21% | eozz0e | Lab C | Public |
| 26 Jan 2026 | DSIP | 5.1 B | 10mg | 9.0mg | -9.6% | 97.88% | 66wk05 | Lab F | Public |
| 9 Jan 2026 | Chonluten | 7.7 A | 50mg | 61.6mg | +23.2% | 99.11% | imq6hm | Lab D | Community |
| 9 Jan 2026 | PEG MGF | 6.1 A | 2mg | 2.0mg | -0.6% | 95.85% | 32bvao | Lab E | Community |
| 12 Dec 2025 | Alprostadil | 5.7 B | 15mg | 13.6mg | -9.0% | 98.76% | yo792m | Lab F | Public |
| 12 Dec 2025 | Livagen | 5.8 B | 5mg | 6.1mg | +21.8% | 95.48% | ubg5cu | Lab D | Public |
| 12 Dec 2025 | RIPEX 225 (TRA/Mast P/Test P) | 4.0 C | 250mg/ml | 253.6mg/ml | +1.4% | 96.63% | 8capku | Lab E | Community |
| 12 Dec 2025 | Vitamin B12 1mg/ml | 8.2 A | 100mg/ml | 107.5mg/ml | +7.5% | 96.29% | yzdopo | Lab E | Community |
| 25 Nov 2025 | Tirzepatide | 6.7 B | 10mg | 9.31mg | -6.9% | 99.64% | (no batch ID) | Lab E | Public |
| 23 Nov 2025 | Super Shred | 4.1 C | 250mg/ml | 243.6mg/ml | -2.6% | 99.66% | dbuni7 | Lab A | Public |
| 23 Nov 2025 | Test Suspension | 4.3 C | 300mg/ml | 292.2mg/ml | -2.6% | 99.23% | r0sj3e | Lab A | Public |
| 17 Nov 2025 | Retatrutide | 8.6 A | 5mg | 4.75mg | -5.0% | 99.30% | October 8, 2025 | Lab E | Public |
| 17 Nov 2025 | AHK-CU | 5.3 B | 20mg | 17.2mg | -14.0% | 99.83% | 4yn6lt | Lab G | Public |
| 14 Nov 2025 | Cerebrolysin | 6.6 A | 30mg | 25.8mg | -13.9% | 96.46% | tjsewv | Lab B | Community |
| 5 Nov 2025 | ACE-031 | 4.5 C | 20mg | 24.1mg | +20.4% | 98.40% | krukfp | Lab F | Public |
| 5 Nov 2025 | PE 22-28 | 4.9 C | 30mg | 33.7mg | +12.3% | 95.46% | 9cbj8n | Lab A | Community |
| 4 Nov 2025 | 1-Boc-4-(4-fluorophenylamino)piperidine CAS 288573-56-8 | 7.7 A | 500g | 504.4g | +0.9% | 99.62% | gdu6uw | Lab D | Public |
| 4 Nov 2025 | Retatrutide 5mg + Cagrilintide 5mg Blend | 5.2 B | 2mg | 2.4mg | +20.1% | 95.70% | e3ua9j | Lab C | Public |
| 4 Nov 2025 | Trestolone Enanthate Raw | 4.0 C | 10g | 11.1g | +10.9% | 99.64% | cvr3dq | Lab G | Public |
| 13 Oct 2025 | Retatrutide | 7.3 A | 10mg | 11mg | +10.0% | 99.40% | 04.Aug.2025 | Lab G | Public |
| 9 Oct 2025 | Testosterone Decanoate Raw | 4.0 C | 10g | 9.8g | -1.6% | 98.27% | x7r3km | Lab A | Community |